Page 1 of 18
Minutes of the Regularly Scheduled Meeting held on October 6, 2016, approved on November 1, 2016
_______
COMMONWEALTH OF MASSACHUSETTSBoard of Registration in Pharmacy
NOTICE OF THE REGULARLY SCHEDULED MEETING OF THEBOARD OF REGISTRATION IN PHARMACY
November 1, 2016239 Causeway Street ~ Room 417 A&B
Boston, Massachusetts 02114
Agenda
Time # Item Exhibits Contact
8:30 I CALL TO ORDER E. Taglieri
8:35 II APPROVAL OF AGENDA Introductions : Nazmin Khalifa - Pharmacy Intern
8:40 III APPROVAL OF BOARD MINUTES Draft of October 6, 2016 Regular Session Minutes
8:45 IV
APPLICATIONS Eaton Apothecary/Lynn Health Center – Relocation Community Health Center of Cape Cod- New Store Brigham and Women’s Hospital- Renovation
9:30 V
REPORTS Applications approved pursuant to Licensure Policy
13-01 Monthly report from probation Board Delegated Complaint Review pursuant to
licensure policy 14-02
ReportsR. HarrisK. Fishman
9:40 VI
POLICIES Proposed policies and standard consent agreement
for PSUD Above action level result staff action policy
V. Berg
M. ChanW. Frisch
10:10 VIIREGULATIONS
247 CMR 18.00: Non-Sterile Compounding 247 CMR 22.00: Fines
W. FrischM. Chan
Page 2 of 18
Minutes of the Regularly Scheduled Meeting held on October 6, 2016, approved on November 1, 2016
_______
10:30 VIII
REGULATORY REVIEW
247 CMR 5.00:Orally and electronically transmitted prescriptions; Prescription Monitoring Program (PMP) reporting requirements
247 CMR 7.00:Wholesale Druggists 247 CMR 9.00:Code of professional conduct;
professional standards for registered pharmacists, pharmacies and pharmacy departments
247 CMR 12.00:Restricted Pharmacy 247 CMR 15.00: Continuous Quality Improvement 247 CMR 20.00:Reporting
V. Berg
11:15 IX
ADVISORY
Advisory on pain management training for pharmacists applying for, or renewing, an individual MCSR pursuant to a CDTM.
M. Chan
11:30 X
FLEX SESSION Nomination for officers Advisory committee update Public Hearing, November 30th at 3p.m.
1. 247 CMR 2.00: Definitions2. 247 CMR 13.00: Registration requirements
and minimal professional standards for nuclear pharmacies.
3. 247 CMR 14.00: Petition for waiver
D. Sencabaugh
V. Thaker
M. Botto
12:00 LUNCH BREAK
Page 3 of 18
Minutes of the Regularly Scheduled Meeting held on October 6, 2016, approved on November 1, 2016
_______
1:00 XI
FILE REVIEW
FILE INVESTIGATOR
1 PHA-2015-0151, New England Life Care, DS3513 Tran
2 PHA-2016-0070, Apothecare Pharmacy, DS89983 Mogni
3 PHA-2016-0122, CVS #17957, DS90007 Santoro
4 SA-INV-10000, Omnicare of Northern MA, DS89931 Santoro
5 PHA-2015-0165, John Fanikos, PH19320 Tran
6 SA-INV-7313, Rite Aid Pharmacy #10085, DS3180 Morton
7 SA-INV-8899, St. Georges Pharmacy Corp., DS90034 Santoro
8 SA-INV-3258,Village Fertility Pharmacy, DS89658 Penta
1:30 XII
EXECUTIVE SESSIONThe Board will meet in Executive Session as authorized pursuant to M.G.L. c. 30A, § 21(a)(1) for the purpose of discussing the reputation, character, physical condition or mental health, rather than professional competence, of an individual, or to discuss the discipline or dismissal of, or complaints or charges brought against, a public officer, employee, staff member or individual.
Specifically, the Board will discuss and evaluate the Good
Moral Character as required for registration for pending applicant.
CLOSED SESSION
2:00 XIII ADJUDICATORY SESSION (M.G.L. c. 30A, § 18) CLOSED SESSION
Page 4 of 18
Minutes of the Regularly Scheduled Meeting held on October 6, 2016, approved on November 1, 2016
_______
2:10 XIV M.G.L. c. 112, § 65C SESSION CLOSED SESSION
5:00 XV ADJOURNMENT
Page 5 of 18
Minutes of the Regularly Scheduled Meeting held on October 6, 2016, approved on November 1, 2016
_______
COMMONWEALTH OF MASSACHUSETTSBOARD OF REGISTRATION IN PHARMACY
MINUTES OF THE REGULARLY SCHEDULED MEETING239 Causeway Street, Fourth Floor Room 417A
Boston Massachusetts, 02114
October 6, 2016
Board Members Present Board Members Not PresentEdmund Taglieri Jr., R.Ph, MSM, NHA William Cox CPhTPresident Richard Tinsley, MBA, M.Ed. Timothy Fensky, R.Ph, FACA Karen Conley, RN, DNPPresident –elect Patrick Gannon, RPh, MSSusan Cornacchio, JD Ali Raja, MD, M.B.A., M.P.H.Phillippe Bouvier, R.Ph.Catherine Basile, Pharm D, R.Ph.Andrew Stein, Pharm D, R.Ph. Michael Godek, R.Ph, SecretaryGarrett Cavanaugh, R.Ph
Board Staff PresentDavid Sencabaugh, R.Ph., Executive DirectorMonica Vasquez, CPhT, Associate Executive DirectorWilliam Frisch, Director of Pharmacy ComplianceMichelle Chan, R.Ph., Quality Assurance PharmacistHeather Engman, JD, MPH Board CounselJoanne Trifone, R.Ph., Director of Pharmacy InvestigationsRichard Harris, Program AnalystJulienne Tran, PharmD, RPh. Pharmacy InvestigatorGreg Melton, JD, R.Ph., Pharmacy InvestigatorVita Palazzolo Berg, JD, Chief Board CounselJoe Santoro, R.Ph. Contract InvestigatorKimberly Morton, CPhT, Compliance OfficerSam Penta, R.Ph. Chief Pharmacy InvestigatorVishal Thaker, Pharm D, R.Ph., Contract Pharmacist
Page 6 of 18
Minutes of the Regularly Scheduled Meeting held on October 6, 2016, approved on November 1, 2016
_______
TOPIC I.CALL TO ORDER 8:35 AMDISCUSSION: A quorum of the Board was present, established by roll call. President E. TAGLIERI chaired the meeting and asked if anyone was recording. Hearing “no”, he explained that the Board of Pharmacy was recording the meeting.
TOPIC II.APPROVAL OF AGENDADISCUSSION: NoneACTION:Motion by C. BASILE, seconded by M. GODEK, and voted unanimously to approve the agenda. P. BOUVIER had not arrived for the vote.Executive Director D. SENCABAUGH introduced APPE student Jordan LACOSTE, from MCPHS University. President Taglieri asked other interns in the room to introduce themselves.
TOPIC III. APPROVAL OF BOARD MINUTES1. Draft August 30, 2016, Regular Session MinutesDISCUSSION: H. ENGMAN recommended removal of the word “warehouse from the minutes on the “US Pharmatrade” application review, and changes to the language on the disposition of the “CureAid” application review.ACTION: Motion by C. BASILE, seconded by G. CAVANAUGH, and voted unanimously to approve the minutes of the Regular Session from August 30, 2016, with noted changes. M. GODEK, A. RAJA, and S. CORNACCHIO abstained, since they were not present on August 30th).
TOPIC IV:APPLICATIONS TIME: 8:42 am
1. Sturdy Memorial Hospital – New Outpatient Retail Pharmacy
RECUSAL: noneDISCUSSION: Sturdy was represented by Mr. Ben Sturm from Integrated Pharmacy Solutions, and by the proposed MOR Mr. Kieran Brennan. Sturm reported that the HCQl had approved the construction at the hospital, while DPH (Nancy O’Leary) had been informed of the planned use of space, and had no objections. The representatives answered the Board members’questions to their satisfaction. They are planning for a February 2017 opening.ACTION: Motion by C BASILE, seconded by, A. STEIN, and voted unanimously in the affirmative to approve the application for the new outpatient retail pharmacy, pending a successful inspection.
Page 7 of 18
Minutes of the Regularly Scheduled Meeting held on October 6, 2016, approved on November 1, 2016
_______
2. KEYES Pharmacy – Renovation / Expansion
RECUSAL: None
DISCUSSION: Keyes Pharmacy was represented by Mr. Ray Dinno, Co-owner and MOR, Mr. SAAD Dinno, Co-owner / RPh, and Mr. Rob Adams from Controlled Environment Structures, who is designing the new clean room. W. FRISCH reported that Board of Pharmacy QA Pharmacists have had discussions with Keyes, reviewed the plans, and are comfortable with them moving forward. Keyes representatives answered the Board Members’ questions to their satisfaction.
ACTION: Motion by A. STEIN second by T. FENSKY, and voted unanimously to approve Keyes Pharmacy to conduct the planned renovation, pending a successful inspection.
3. MEDMINDER SYSTEMS - Relocation
RECUSAL: Phil Bouvier (arrived at 9:04 and immediately recused)
DISCUSSION: Medminder Systems was represented by Brian Bouvier, Operations Manager. Medminder is moving from Marlborough to Needham for growth and consolidation reasons. Mr. Bouvier presented two options to the Board, and the Board voted to approve the second option, showing the sink located more proximal to the prescription filling area. Two separate actions were taken:
ACTION: Motion by M. GODEK, seconded by G. CAVANAUGH, and voted unanimously to deny the first set of plans showing the sink in a separate area, somewhat distant from the actual prescription filling section of the pharmacy.
ACTION: Motion by T. FENSKY, seconded by, C. BASILE, and voted unanimously in the affirmative to approve the application for relocation showing the sink in the prescription filling area, pending the addition of a splashguard, and a successful inspection.
4. New England Home Therapies – Renovation / Expansion
RECUSAL: None
DISCUSSION: New England Home Therapies was represented by MOR Gina Matthews, Operations Manager Mike Carroll, Tom Choate from Air Systems Technologies, and Rick Coan from CES (Construction Engineering.)
Page 8 of 18
Minutes of the Regularly Scheduled Meeting held on October 6, 2016, approved on November 1, 2016
_______
W. FRISCH informed the Board that QA Pharmacists from Board Staff have been in communication with NEHT, and that they are comfortable with them moving forward. NEHT answered the Board’s questions to their satisfaction, and they committed to a stepped-up EM schedule, during the process; 2x /month until containment is proven, then monthlyACTION: Motion by T. FENSKY second by M. GODEK, and voted unanimously by those present to approve New England Home Therapies’ plans for renovation and expansion, pending a successful inspection.
TOPIC V.
REPORTSApplications Approved Pursuant to Licensure Policy 13-01, 16-01 9:01 am
DISCUSSION: R. HARRIS noted that during the past month there have been twenty-five (25) change-of-managers, two (2) new Community Pharmacies, one (1) closing, three (3) renovations/ expansions, and eleven (8) registered non-resident Outsourcing Facilities.
Board Delegated Review Pursuant to BDCR PolicyThere was 1 Board Delegated Review case heard on September 29, 2016 involving self-reports of CE deficiency. It had been satisfactorily remediated and the file was closed with no discipline warranted. The Board Delegated Review session was attended by E.TAGLIERI as the Board Member, H. ENGMAN as Board Counsel, W. FRISCH, Director of Pharmacy Compliance, and Executive Director D. SENCABAUGH.
ACTION: So noted
Report of activities Probation MonitorDISCUSSION: D. SENCABAUGH (for K.FISHMAN) provided the August 19, 2016 – September 27, 2016, Board of Pharmacy Statistics Report for the Probation monitor, which noted that: there are forty-five (45) licensees on probation, thirty-one (31) satisfactorily completed probation, four (4) licensee did not cure within 30 days, eight (8) given the opportunity to cure, and two (2) notices of further discipline.
ACTION: So noted
Page 9 of 18
Minutes of the Regularly Scheduled Meeting held on October 6, 2016, approved on November 1, 2016
_______
TOPIC VI POLICIES Time: 10:10am
Proposed policy and standard consent agreement for PSUD
Discussion: Board members received a copy of statue Chapter 112, section 24 H effective March 2016. V.Berg outlined the statue for board members and distributed a preliminary draft of a consent agreement. This topic will be revisited at the November Board meeting, where a vote is likely.
M: Ed, Tim, Cathy, Susan, Phil, Andy, Patrick, Garrett, Ali, MikeS: Ed, Tim, Cathy, Susan, Phil, Andy, Patrick, Garrett, Ali, MikeV:
TOPIC VII Regulations
Section 18:00 Non-Sterile Compounding
Discussion: Public comment collated and reviewed with Board members. Recommendations made by Board staff. Next steps will be to redraft and have 1 vote at the November meeting then it moves to administrative review.
Action: None at this time. Vote of redraft planned for November meeting.
M: Ed, Tim, Cathy, Susan, Phil, Andy, Patrick, Garrett, Ali, MikeS: Ed, Tim, Cathy, Susan, Phil, Andy, Patrick, Garrett, Ali, Mike
Section 19:00 Hazardous Medication
Discussion: Guidance document will be developed pertaining to OSHA items. No substantive change to proposed regulations therefore went to vote.
ACTION: Motion by M. GODEK, seconded by C. BASILE, and voted unanimously by those present, to approve section 19 to be sent for Administrative Review and public comments.
TOPIC VIII: FLEX SESSION TIME: 9:26am
Page 10 of 18
Minutes of the Regularly Scheduled Meeting held on October 6, 2016, approved on November 1, 2016
_______
Announcement of Board Officer Elections for 2017Presented by: Dave Sencabaugh
Discussion: Nominations for officers will take place at the November meeting. Open positions will be for President-Elect and Secretary. Current President –Elect, Tim Fensky will become President. Executive Director Sencabaugh reminded Board members that they can’t discuss this with each other.
TOPIC VIII FLEX SESSION Time: 9:26am
NABP District I + II meeting Update:Presented by: Tim Fensky
The meeting was held September 15 — 17, 2016 at The Greenbrier Resort in White Sulphur Springs, West Virginia (District II). In attendance were Dave Sencabaugh, Tim Fensky, and Garret Cavanaugh. Topics discussed were the Opioid Crisis and Substance Use Disorder; Changing How the Pharmacist is looking at the Healthcare System, Prescriptive Authority. In the business session an update of NABP’s status was given. Three resolutions were presented by Anita Young, District I contact person. District II backed one of the District I proposed resolutions. District I will still submit the other two resolutions without the backing of District II. Garret Cavanaugh was nominated to be on the Resolutions Committee for the annual meeting to be held in May of 2016. Robert Carpenter of VT will be the alternate.
So noted
TOPIC VIII FLEX SESSION Time: 9:24am
Announcement of 10/14 Advisory Committee Meeting:Presented by: Dave Sencabaugh
The next meeting of the Advisory Committee will be held on Friday October 14, 2016. This meeting will be open to the public. The three main topics to be discussed will be:
1) Follow up and finish the protocol when a licensee receives an above action level notification (guidance for Board staff &/ registrant)
2) Scope of practice of technicians with regard to technology3) Telepharmacy-Chapter 159 will be addressed4)
TOPIC: IX File ReviewCase #1SA-INV-9196 Owens and Minor Distribution, WD53 TIME: 11:45 RECUSAL: NONEDISCUSSION: G. MELTON presented and summarized the investigation report that
pertained to these matters.
Page 11 of 18
Minutes of the Regularly Scheduled Meeting held on October 6, 2016, approved on November 1, 2016
_______
Owens & Minor notified the MA Board on 1/25/16 of reciprocal discipline by the AL Board related to discipline by the VT board against their facility in TX.
Vermont Board disciplined Owens & Minor for failing to disclose all prior discipline in 6 states including their own ( for their facility in CA) in an application for out of state licensure for the TX facility
•The VT discipline resulted in reciprocal discipline in AL, HI, & WI •When the TX facility was originally disciplined in VT it was not licensed by the MA
board •The Franklin, MA facility was licensed in MA when the reciprocal discipline was issued in AL therefore reported to MA
ACTION: Motion by C. BASILE, seconded by T. FENSKY, and voted unanimously by those present, to close SA-INV-9196, no violation.
Case #2PHA-2016-0047 Ashburnham Family Pharmacy, DS3314 TIME: 11:46 AMRECUSAL: S. CORNACCHIO recused and was not present for the discussion or vote
on this matter.DISCUSSION: G. MELTON presented and summarized the investigation report that
pertained to these matters. A technician in training was observed working in excess of 1000 hours during retail
compliance inspections on 5/12/15 and 8/7/15. •The MORs plan of correction indicated that at the end of April 2015 he was aware the
technician trainee had exceeded 1000 hours. •At that time an application for licensure was completed but never submitted by
corporate. •MOR indicated the technician in training stopped working in that capacity after the
May inspection. Observations to the contrary were made during the follow up inspection in August
•MOR indicated he believed the application was in progress. Technician eventually licensed 10/13/15.
ACTION: Motion by A. STEIN, seconded by C. BASILE, and voted unanimously by those present, to dismiss PHA-2016-0047, no discipline warranted.
Case #3PHA-2016-0048 Michael Webb, PH18093 TIME: 11:46 AMRECUSAL: S. CORNACCHIO recused and was not present for the discussion or vote
on this matter.
DISCUSSION: G. MELTON presented and summarized the investigation report that pertained to these matters.
Page 12 of 18
Minutes of the Regularly Scheduled Meeting held on October 6, 2016, approved on November 1, 2016
_______
A technician in training was observed working in excess of 1000 hours during retail compliance inspections on 5/12/15 and 8/7/15.
•The MORs plan of correction indicated that at the end of April 2015 he was aware the technician trainee had exceeded 1000 hours.
•At that time an application for licensure was completed but never submitted by corporate.
•MOR indicated the technician in training stopped working in that capacity after the May inspection. Observations to the contrary were made during the follow up inspection in August
•MOR indicated he believed the application was in progress. Technician eventually licensed 10/13/15.
ACTION: Motion by M. GODEK, seconded by G. CAVANAUGH, and voted unanimously by those present, to refer the matter to the office of the prosecution for the issuance of an order to show cause and to authorize resolution of the matter by a consent agreement for stayed probation with special terms to include reading, and attest to having read the following: 247 CMR sections 6, 8,9 as well as the Manager of Record Checklist. Furthermore, licensee must complete an additional 2 CEs in pharmacy law.
Case #4SA-INV-9667 Lynnfield Drug, Inc/ Freedom Fertility Pharmacy, DS89717
TIME: 11:44 AMRECUSAL: NONE
DISCUSSION: J. SANTORO presented and summarized the investigation report that pertained to these matters.
•Timely self report of an abnormal result from 6/13/16 •Reduced BUDs following guidelines of draft regulations 247 CMR 17 •Remediation was completed; compounding resumed 6/24/16 after approval from
the board ACTION: Motion by T. FENSKY, seconded by C. BASILE, and voted unanimously
by those present, to close SA-INV-9667, no violation. Case #5PHA-2016-0060 Pharm Blue Mass, LLC, DS89961 TIME: 11:55 AMRECUSAL: NONE
DISCUSSION: J. SANTORO presented and summarized the investigation report that pertained to these matters.
•Regulatory code violation involving proper maintenance of records
Page 13 of 18
Minutes of the Regularly Scheduled Meeting held on October 6, 2016, approved on November 1, 2016
_______
•The pharmacy scanned C VI prescriptions into the computer and then shredded the hard copies •The prescriptions were maintained in Docu Tract Software which the pharmacy thought met the requirements of the board •New policy implemented to comply with record retention requirements and
prescriptions were retrieved from the system, printed and filed on site. ACTION: Motion by C. BASILE, seconded by S. CORRNACHIO, and voted unanimously by those present, to dismiss PHA-2016-0060, no discipline warranted.
Case #6SA-INV-9016 Omnicare of Northern MA, DS89931 TIME: 11:57 AMRECUSAL: S. CORNACCHIO recused and was not present for the discussion or vote on
this matter.
DISCUSSION: J. TRAN presented and summarized the investigation report that pertained to these matters.
• DEA 106-8 hydromorphone 4mg tabs on or about 1/19/16• Discovered while performing weekly perpetual inventory count. • Possible contributing factors-human error, process error, inventory discrepancy• A review of perpetual inventory calculations, item usage report, drug verification error report, cancelled full report, duplicate label report and no discrepancies detected. Video surveillance reviewed as well with no evidence of suspicious activity.• Corrective action is to put medication on a daily count if shows a loss to look for trends or a pattern of no discrepancies
ACTION: Motion by C. BASILE, seconded by A. STEIN, and voted unanimously by those present, to close SA-INV-9016, insufficient evidence.
Case #7SA-INV-9662 CVS #1143, DS1713 TIME: 11:59 AMRECUSAL: S. CORNACCHIO recused and was not present for the discussion or vote on
this matter.
DISCUSSION: J. SANTORO presented and summarized the investigation report that pertained to these matters.
Page 14 of 18
Minutes of the Regularly Scheduled Meeting held on October 6, 2016, approved on November 1, 2016
_______
•Staff Assignment opened due to an Inspectional deficiency of improper technician ratio •Technician trainee was assigned to this training store by the training department •The plan of correction indicated the ratio was exceeded because the technician tasked with training the trainee was not properly identified as "coach" via their name badge and absence of a white lab coat •Technician trainers were also reminded they will only observe and coach trainee and not engage in any technician duties while training
ACTION: Motion by G. CAVANAUGH, seconded by C. BASILE, and voted unanimously by those present, to close SA-INV-9016, and to send licensee advisory on staff ratios.
Case #8SA-INV-9739 CVS #1007, DS2629 TIME: 12:00 PMRECUSAL: S. CORNACCHIO recused and was not present for the discussion or vote on
this matter.
DISCUSSION: J. SANTORO presented and summarized the investigation report that pertained to these matters.
•DEA 106- 453 clonazepam 0.5mg tabs on or about 3/1/16 due to an incorrect 2015 biennial inventory •Loss was identified during corporate CS monitoring •A full investigation did not reveal any evidence of diversion or gross violation of current policy. An explanation of the loss was not uncovered. •Corrective action includes double counting of CS prior to dispensing, retraining of technicians who handle damage drug or outdates, coaching on importance of checking in CS inventory completely before an inventory check is entered into record
ACTION: Motion by T. FENSKY, seconded by G. CAVANAUGH, and voted unanimously by those present, to close SA-INV-9739, no discipline warranted.
Case #9SA-INV-9730 CVS #594, DS89964 TIME: 12:02 PMRECUSAL: S. CORNACCHIO recused and was not present for the discussion or vote on
this matter.
DISCUSSION: J. SANTORO presented and summarized the investigation report that pertained to these matters.
Page 15 of 18
Minutes of the Regularly Scheduled Meeting held on October 6, 2016, approved on November 1, 2016
_______
•DEA 106-299 tramadol 50mg on or about 4/20/16 identified via corporate CS monitoring •Full investigation did not reveal any evidence of diversion or gross violation of current policy. An explanation of the loss was not uncovered.
•Corrective action includes double counting of CS before dispensing, retraining of technicians who handle damage drug or outdates, reviewed baseline loss prevention procedures with staff, specifically those that prevent drug diversion.ACTION: Motion by C. BASILE, seconded by G. CAVANAUGH, and voted unanimously by those present, to close SA-INV-9730, no discipline warranted.
TOPIC XEXECUTIVE SESSIONDISCUSSION: NoneACTION: At 1:10 pm President Taglieri called for a motion to enter Executive Session: Motion by T. FENSKY seconded by M. GODEK and voted unanimously by roll call to enter into Executive Session. E. TAGLIERI; yes, T. FENSKY; yes, P. BOUVIER; yes, C. BASILE; yes, S. CORNACCHIO yes, A. STEIN: yes G. CAVANAUGH: yes; A. RAJA; yes, M. GODEK; yes
At 1:47 pm motion by T. FENSKY seconded by C. BASILE, and voted unanimously by roll call to adjourn Executive session. E. TAGLIERI; yes, T. FENSKY; yes, P. BOUVIER; yes, C. BASILE; yes, S. CORNACCHIO yes, A. STEIN: yes G. CAVANAUGH: yes; A. RAJA; yes, M. GODEK; yes
TOPIC XIAdjudicatory SessionDISCUSSION: NoneACTION: At 1:48 pm, on a motion by T. FENSKY, seconded by C. BASILE, the members voted unanimously to enter into Adjudicatory session.
At 1:51 pm motion by G. CAVANAUGH seconded by C. BASILE, the members voted unanimously to adjourn Adjudicatory Session.
TOPIC XII.M.G.L. c. 65C SessionDISCUSSION: NoneACTION: At 1:52 pm motion by A. STEIN, seconded by A. RAJA and voted unanimously to enter into M.G.L. c. 65C Session. (Susan Cornacchio was not in the room for that vote)
Page 16 of 18
Minutes of the Regularly Scheduled Meeting held on October 6, 2016, approved on November 1, 2016
_______
ACTION: At 3:16 pm motion by M. GODEK, seconded by G. CAVANAUGH and voted unanimously to adjourn M.G.L. 65 C.
TOPIC XIII.ADJOURMENT OF MEETINGDISCUSSION: NONEACTION: At 3:18 pm motion by G. CAVANAUGH, seconded by C. BASILE, and voted unanimously to adjourn the meeting.
Page 17 of 18
Minutes of the Regularly Scheduled Meeting held on October 6, 2016, approved on November 1, 2016
_______
EXHIBITS USED DURING THE OPEN SESSION OF THE MEETING
1. Draft Agenda for the October 6, 2016, regularly scheduled meeting of the Board of Registration in Pharmacy.
2. Draft August 30, 2016 Open Session Minutes.3. Application for New Outpatient Retail Pharmacy Sturdy Memorial4. Application for Renovation / Expansion Keyes Pharmacy5. Application for Renovation / Relocation of Medminder Systems6. Application for Renovation New England Home Therapies7. Report of Applications approved pursuant to licensure policy 13-018. Report of Application information pursuant to licensure policy 16-019. Report from Probation Monitor 8/19/2016 – 9/27/201610. Board Delegated Compliant Review report 9/29/201611. Draft proposed changes to regulation 247 CMR 18.00: Non-Sterile Compounding per
public testimony. 12. Draft proposed regulation 247 CMR 19:00: Hazardous Medication12. Investigation report in the matter of Owens and Minor, WD353, SA-INV-919613. Investigation report in the matter of Ashburnham Pharmacy, DS3314, PHA-2016-004715. Investigation report in the matter of Michael A. Webb, PH18093, PHA-2016-004816. Investigation report in the matter of Lynnfield Drug Inc. / Freedom Fertility Pharmacy, DS89717, SA-INV-966717. Investigation report in the matter of Pharm Blue Mass, DS89961, PHA-2016-006018. Investigation report in the matter of Omnicare of Northern Mass, DS89931, SA-INV-901619. Investigation report in the matter of CVS #1143, DS1713,SA-INV-966220. Investigation report in the matter of CVS #1007, DS2629, SA-INV-973921. Investigation report in the matter of CVS #594, DS89964, SA-INV-9730
Respectfully submitted by:M. GODEK, R.Ph.
_________________________
_________________________
Page 18 of 18
Minutes of the Regularly Scheduled Meeting held on October 6, 2016, approved on November 1, 2016
_______